A_DT
chimeric_JJ
type_NN
II_CD
\/_:
type_NN
I_CD
interleukin-1_NN
receptor_NN
can_MD
mediate_VB
interleukin-1_NN
induction_NN
of_IN
gene_NN
expression_NN
in_IN
T_NN
cells_NNS
._.

The_DT
type_NN
I_CD
interleukin-1_NN
receptor_NN
-LRB-_-LRB-
IL-1R_NN
-RRB-_-RRB-
is_VBZ
capable_JJ
of_IN
transducing_VBG
a_DT
signal_NN
resulting_VBG
in_IN
promoter_NN
activation_NN
in_IN
T_NN
cells_NNS
._.

This_DT
signal_NN
transduction_NN
is_VBZ
dependent_JJ
on_IN
the_DT
cytoplasmic_JJ
domain_NN
,_,
which_WDT
consists_VBZ
of_IN
213_CD
amino_NN
acids_NNS
._.

In_IN
contrast_NN
to_TO
the_DT
type_NN
I_NN
receptor_NN
,_,
the_DT
type_NN
II_CD
IL-1R_NN
has_VBZ
a_DT
small_JJ
cytoplasmic_JJ
tail_NN
,_,
and_CC
it_PRP
is_VBZ
not_RB
clear_JJ
whether_IN
this_DT
receptor_NN
is_VBZ
a_DT
signal-transducing_JJ
or_CC
a_DT
regulatory_JJ
molecule_NN
._.

Here_RB
we_PRP
report_VBP
that_IN
the_DT
type_NN
II_CD
IL-1R_NN
does_VBZ
not_RB
mediate_VB
gene_NN
activation_NN
in_IN
Jurkat_NN
cells_NNS
._.

However_RB
,_,
a_DT
hybrid_NN
receptor_NN
composed_VBN
of_IN
the_DT
extracellular_JJ
and_CC
transmembrane_NN
regions_NNS
of_IN
the_DT
human_JJ
type_NN
II_CD
interleukin-1_NN
fused_VBN
to_TO
the_DT
cytoplasmic_JJ
domain_NN
of_IN
the_DT
human_JJ
type_NN
I_NN
IL-1R_NN
was_VBD
capable_JJ
of_IN
transducing_VBG
a_DT
signal_NN
across_IN
the_DT
membrane_NN
resulting_VBG
in_IN
a_DT
pattern_NN
of_IN
gene_NN
activation_NN
identical_JJ
to_TO
that_DT
mediated_VBN
by_IN
the_DT
type_NN
I_NN
IL-1R_NN
._.

Our_PRP$
results_NNS
indicated_VBD
that_IN
the_DT
extracellular_JJ
domain_NN
of_IN
the_DT
type_NN
II_CD
IL-1R_NN
was_VBD
capable_JJ
of_IN
functionally_RB
interacting_VBG
with_IN
interleukin-1_NN
and_CC
transmitting_VBG
the_DT
resulting_VBG
signal_NN
to_TO
a_DT
heterologous_JJ
cytoplasmic_JJ
domain_NN
._.

